Equivalent Peri-Operative Outcomes for Laparoscopic Roux-En-Y Gastric Bypass Patients Discharged on Post-Operative Day One.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 21 4 2019
medline: 23 4 2020
entrez: 21 4 2019
Statut: ppublish

Résumé

Previous studies have evaluated the safety of post-operative day one (POD #1) discharge after laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery. Few studies, however, have evaluated the impact of a standardized POD #1 discharge pathway on peri-operative outcomes. This study aims to evaluate peri-operative outcomes after implementation of an enhanced recovery pathway for RYGB patients. Data from a prospectively maintained database identified 2,049 patients (pre-implementation n = 904; post-implementation n = 1,144) who underwent LRYGB between 2008 and 2016. The POD1 discharge pathway was implemented in July 2011. Patient demographics and outcomes before and after implementation of the POD1 pathway were compared using univariate analysis and propensity matching. A propensity-matched group of all patients (n = 714) and POD #1 candidates (n = 490) pre- and post-pathway implementation were analyzed. Successful POD #1 discharges were significantly increased after introduction of the pathway (54.3 vs 17.8%, p < 0.0001). The post-implementation groups demonstrated no differences in mortality, Emergency department (ED) visits, readmissions, reoperations, and major or minor complications. Early discharge after bariatric surgery has a significant impact on the cost effectiveness of surgery, patient comfort, potential reduction of medical errors, and exposure to hospital-acquired infections. Our results demonstrate that a standardized POD #1 discharge pathway can be safely implemented and in turn, reduce hospital LOS without negatively affecting peri-operative morbidity, mortality, ED visit, readmission, or reoperation rates.

Sections du résumé

BACKGROUND
Previous studies have evaluated the safety of post-operative day one (POD #1) discharge after laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery. Few studies, however, have evaluated the impact of a standardized POD #1 discharge pathway on peri-operative outcomes. This study aims to evaluate peri-operative outcomes after implementation of an enhanced recovery pathway for RYGB patients.
METHODS
Data from a prospectively maintained database identified 2,049 patients (pre-implementation n = 904; post-implementation n = 1,144) who underwent LRYGB between 2008 and 2016. The POD1 discharge pathway was implemented in July 2011. Patient demographics and outcomes before and after implementation of the POD1 pathway were compared using univariate analysis and propensity matching.
RESULTS
A propensity-matched group of all patients (n = 714) and POD #1 candidates (n = 490) pre- and post-pathway implementation were analyzed. Successful POD #1 discharges were significantly increased after introduction of the pathway (54.3 vs 17.8%, p < 0.0001). The post-implementation groups demonstrated no differences in mortality, Emergency department (ED) visits, readmissions, reoperations, and major or minor complications.
CONCLUSIONS
Early discharge after bariatric surgery has a significant impact on the cost effectiveness of surgery, patient comfort, potential reduction of medical errors, and exposure to hospital-acquired infections. Our results demonstrate that a standardized POD #1 discharge pathway can be safely implemented and in turn, reduce hospital LOS without negatively affecting peri-operative morbidity, mortality, ED visit, readmission, or reoperation rates.

Identifiants

pubmed: 31004268
doi: 10.1007/s11695-019-03884-7
pii: 10.1007/s11695-019-03884-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2392-2398

Références

Surg Endosc. 2016 Jun;30(6):2342-50
pubmed: 26307598
Ann Surg. 2014 Jan;259(1):123-30
pubmed: 23470583
Surg Obes Relat Dis. 2016 Jan;12(1):119-26
pubmed: 25892343
Obes Surg. 2016 Mar;26(3):505-11
pubmed: 26205214
Surg Obes Relat Dis. 2017 Feb;13(2):273-280
pubmed: 27986577
Surg Obes Relat Dis. 2014 May-Jun;10(3):392-5
pubmed: 24951064
Surg Endosc. 2017 Feb;31(2):618-624
pubmed: 27338582
Surgery. 2015 Aug;158(2):501-7
pubmed: 26032831
J Gastrointest Surg. 2002 Nov-Dec;6(6):855-60; discussion 861
pubmed: 12504224
Ann Surg. 2014 Sep;260(3):504-8; discussion 508-9
pubmed: 25115426
Obes Surg. 2014 Mar;24(3):390-6
pubmed: 24254930

Auteurs

Jarrod M Buzalewski (JM)

Department of Bariatric and Foregut Surgery, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA, 17822, USA. jbuzalewski@geisinger.edu.

Mark E Mahan (ME)

Department of Bariatric and Foregut Surgery, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA, 17822, USA.

Marcus Fluck (M)

Department of Bariatric and Foregut Surgery, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA, 17822, USA.

James Dove (J)

Department of Bariatric and Foregut Surgery, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA, 17822, USA.

Ryan D Horsley (RD)

Department of Bariatric and Foregut Surgery, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA, 17822, USA.

David M Parker (DM)

Department of Bariatric and Foregut Surgery, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA, 17822, USA.

Anthony T Petrick (AT)

Department of Bariatric and Foregut Surgery, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA, 17822, USA.

Jon D Gabrielsen (JD)

Department of Bariatric and Foregut Surgery, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA, 17822, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH